2 news · updated just now

Cipla Q1 profit miss

2026-10-27

India's Cipla misses quarterly profit view on muted US sales

India's Cipla missed Q2 profit estimates as net earnings fell to 8.78 billion rupees due to weak US sales of generic Revlimid. While North American revenue declined 19%, Indian operations grew 12%, pa

reuters · 2026-10-27 00:58 UTC

2026-07-22

Indian drugmaker Cipla's Q1 profit misses estimates

Cipla's Q1 profit fell 39.2% to 7.89 billion rupees, missing estimates due to muted generic cancer drug sales and supply disruptions affecting lanreotide in its U.S. business.

reuters · 2026-07-22 23:40 UTC

Cipla Q1 profit miss

India's Cipla misses quarterly profit view on muted US sales

Indian drugmaker Cipla's Q1 profit misses estimates

Media coverage (2)

Related topics